Introducing a New Pharma Ad Solution with Multi-CTA Attachments

Pharma marketers are navigating a more complex environment than ever. Health and wellness conversations increasingly happen on social platforms nowadays, with a whopping 95% of Snapchatters stating they have an active interest in the topic. ¹ Meanwhile, marketers must also comply with industry regulations and prove the business impact of their campaigns.

That’s why today, we're announcing a new ad format now available for US pharma marketers: multi-CTA attachments that will support the disclosure needs of branded Rx campaigns and help advertisers activate more confidently on Snapchat. For pharma marketers, Snapchat offers access to a broad and engaged audience, with more than 80% of Snapchatters over the age of 18² and over 50% of US Snapchatters over the age of 25.³

Every patient, caregiver, and healthcare professional may need different resources depending on where they are in their healthcare journey. This is why marketers often need more than a single click-out to run branded campaigns. In addition to the primary brand destination, many campaigns require links to critical information such as safety guides accessible within one click from the ad.

Our new multi-CTA attachments are designed to address those specific needs, so pharma advertisers face less limitations in the ad formats they can use and scale their campaigns across our platform. Brands can configure up to three disclaimer CTAs alongside a primary CTA, helping unlock more compliant campaign setups across Snap Ads, Story Ads, Commercials, and, later this year, Sponsored Snaps.

As the needs of pharma advertisers continue to evolve, we're focused on building solutions that help brands remain compliant, reach the right audiences, and measure what matters.